1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research & Forecasting
2.1. Research Methodology
2.1.1. Research Process
2.1.2. Research Framework
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.2. Forecasting Methodology
2.3. Research Outcome
2.3.1. 360iResearch Competitive Strategic Window
2.3.1.1. Leverage Zone
2.3.1.2. Vantage Zone
2.3.1.3. Speculative Zone
2.3.1.4. Bottleneck Zone
2.3.2. 360iResearch FPNV Positioning Matrix
2.3.2.1. 360iResearch Quadrants
2.3.2.1.1. Forefront
2.3.2.1.2. Pathfinders
2.3.2.1.3. Niche
2.3.2.1.4. Vital
2.3.2.2. Business Strategy
2.3.2.2.1. Business Growth
2.3.2.2.2. Industry Coverage
2.3.2.2.3. Financial Viability
2.3.2.2.4. Channel Support
2.3.2.3. Product Satisfaction
2.3.2.3.1. Value for Money
2.3.2.3.2. Ease of Use
2.3.2.3.3. Product Features
2.3.2.3.4. Customer Support
3. Executive Summary
3.1. Outlook in the Narcolepsy Treatment Market
3.2. Opportunities in the Narcolepsy Treatment Market
4. Premium Insight
4.1. Market Connectivity
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Porter's Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Customers
4.3.4. Bargaining Power of Suppliers
4.3.5. Industry Rivalry
4.4. Industry Trends
5. Global Narcolepsy Treatment Market, by Drug Class
5.1. Overview
5.2. Market Sizing & Forecasting
5.3. CNS Stimulants
5.4. Decongestants
5.5. Serotonin Reuptake Inhibitors
5.6. Vasopressors
6. Global Narcolepsy Treatment Market, by Narcolepsy Type
6.1. Overview
6.2. Market Sizing & Forecasting
6.3. Narcolepsy Type 1
6.4. Narcolepsy Type 2
7. Global Narcolepsy Treatment Market, by End User
7.1. Overview
7.2. Market Sizing & Forecasting
7.3. Drug Stores
7.4. E-commerce
7.5. Retail Pharmacies
8. Global Narcolepsy Treatment Market, by Geography
8.1. Overview
8.2. Market Sizing & Forecasting
8.3. Americas
8.3.1. Overview
8.3.2. Market Sizing & Forecasting
8.3.3. Argentina
8.3.4. Brazil
8.3.5. Canada
8.3.6. Mexico
8.3.7. United States
8.4. Asia-Pacific
8.4.1. Overview
8.4.2. Market Sizing & Forecasting
8.4.3. Australia
8.4.4. China
8.4.5. India
8.4.6. Japan
8.5. Europe, Middle East & Africa
8.5.1. Overview
8.5.2. Market Sizing & Forecasting
8.5.3. France
8.5.4. Germany
8.5.5. Italy
8.5.6. Spain
8.5.7. United Kingdom
9. Competitive Landscape
9.1. 360iResearch FPNV Positioning Matrix for Global Narcolepsy Treatment Market
9.2. Market Vendor Ranking Analysis for Global Narcolepsy Treatment Market
9.3. Competitive News Feed Analysis for Global Narcolepsy Treatment Market
10. Company Usability Profiles
10.1. Arena Pharmaceuticals, Inc.
10.1.1. Overview
10.1.2. Strategy
10.1.3. SWOT
10.2. Graymark Healthcare Inc.
10.2.1. Overview
10.2.2. Strategy
10.2.3. SWOT
10.3. Ligand Pharmaceuticals
10.3.1. Overview
10.3.2. Strategy
10.3.3. SWOT
10.4. Shire Plc
10.4.1. Overview
10.4.2. Strategy
10.4.3. SWOT
10.5. Teva Pharmaceutical Industries Ltd.
10.5.1. Overview
10.5.2. Strategy
10.5.3. SWOT
10.6. Jazz Pharmaceuticals plc
11. Appendix
11.1. Discussion Guide
11.2. Top Reports
11.2.1. Global Crane Rental Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.2. Global Computer Vision Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.3. Global Payment Gateway Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.4. Global B2B Travel Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.5. Global Varicose Vein Treatment Devices Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.3. Author Details